Syros Pharmaceuticals

Historical price data

Syros Pharmaceuticals (NASDAQ: SYRS) is a biopharmaceutical company based in the United States. Its primary business focus is the development of treatments for cancer and other diseases by targeting gene expression control mechanisms. The company's platform is designed to identify and drug specific gene regulatory regions to modulate the expression of genes known to drive disease. The company's pipeline consists of seven drug candidates. Its lead therapeutic area is oncology, with clinical-stage programs investigating treatments for hematologic malignancies and solid tumors. Syros's research and development efforts are centered on transcription factors and other regulators of gene expression, which are implicated in a range of serious medical conditions. As a publicly traded entity, Syros Pharmaceuticals advances its candidates through clinical development. The company's corporate and scientific information, including details on its pipeline and research approach, is available through its official website and regulatory filings with the U.S. Securities and Exchange Commission.